Home » Headlines » Currently Reading:

Morning Headlines 2/20/17

February 19, 2017 Headlines 4 Comments

Opening Keynote: The Art of Deception: How Hackers and Con Artists Manipulate You and What You Can Do About It

HIMSS17 kicks off as white coat hacker Kevin Mitnick takes the stage to discuss emerging cybersecurity threats and how to detect and defend against them.

Touted IBM supercomputer project at MD Anderson on hold after audit finds spending issues

Auditors find that MD Anderson Cancer Center’s now stalled effort to employ IBM Watson in the fight against cancer was paid for with funds that were secured by hospital executives that intentionally sidestepped purchasing rules.

$5.5 million HIPAA settlement shines light on the importance of audit controls

Memorial Healthcare Systems (FL) pays $5.5 million to settle HIPAA violations after discovering that a former employee continued to use his login credentials to access more than 80,000 patient records without permission.

Forbes World’s Most Admired Companies

Cerner, CVS Health, St. Jude Medical Abbott Laboratories, and Aetna are named to Forbes Most Admired Companies list.

View/Print Text Only View/Print Text Only


HIStalk Featured Sponsors

     

Currently there are "4 comments" on this Article:

  1. RE: MD Anderson & IBM Watson – Another $60M out the door for another IT project, this time IBM Watson…comes on the heels of a $405M drop in net income attributed to Epic. A publicly available audit report says Watson couldn’t work with Epic. Maybe Epic isn’t as ‘Open’ as Judy claims.

  2. The University of Texas audit is instructive. File this one under Innovation Management 101. The IBM Watson project is highly experimental and should not be governed like a traditional project. Risks should have been clearly articulated upfront. Kudos for an attempt to break new ground. Always expect set backs, that’s what innovation is all about. However, is MD Anderson the only party at risk ($$$$)? The onus is on MD Anderson to broker a win-win deal. Did the others have skin in the game, or did they just sell a bunch of h/w, s/w and services like a traditional project? Someone made quota on this deal, but to what end? Dream big, but plan SMALL.

  3. RE — Watson & Nant: Not a great two weeks for the leading Cancer Moonshot vendors. Last week Slate takes apart Nant Health, this week Forbes finds that IBM is completely ineffective at MD Anderson and being scrapped after a $60M investment, with MD Anderson going back to bid. Sounds like vaporware working at its best.







Subscribe to Updates

Search


Loading

Text Ads


Report News and Rumors

No title

Anonymous online form
E-mail
Rumor line: 801.HIT.NEWS

Tweets

Archives

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reader Comments

  • Brian Too: While I'm usually pretty forgiving about individual stylistic variations, I will say that I found Ed's final paragraph e...
  • From the Inside: It's great to see that Ed was so impactful on the NYC H+H IT "broken division" in his continuing quest to save the worl...
  • AynRandWasDumb: This article is so vague it amounts to platitude. What is my takeaway as a reader? That Ed did such a great job and he h...
  • Brian Too: I've always loved AC/DC. One tidbit others might enjoy. The movie "School of Rock" performed an awesome cover of "It...
  • Steve Natz: I have been a reader of HIStalk for several years and have always enjoyed these articles along with the industry news to...

Sponsor Quick Links